California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say consumers will be able to purchase a five-pack of insulin pens for $55 in ...

The United States Rapid Acting Insulin Market is poised for significant growth, increasing from US$ 2.32 Billion in 2024 to US$ 3.40 Billion by 2033, with a CAGR of 4.33%. Key growth drivers include ...

A Polish study comparing insulin pump technologies in children with type 1 diabetes found that advanced hybrid closed-loop ...

Mounjaro is a prescription injection that can be used to help manage blood sugar levels in adults with type 2 diabetes. It can be administered as an injection under the skin in your abdomen, thigh, or ...

LOS ANGELES (AP) — Gov. Gavin Newsom said Thursday that California will begin selling affordable insulin under its own label on Jan. 1, nearly three years after he first announced a partnership to ...

Since her 2021 diabetes diagnosis, Stephanie Guignard, a nurse practitioner, has made it her mission to educate people on how ...

Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "United States Rapid Acting Insulin Market Report by Product, Indication, Distribution Channel, States and Company Analysis, 2025-2033" report has been ...

The Global Diabetes Devices Market is projected to expand at a compound annual growth rate (CAGR) of approximately 6% by 2026. Key drivers of this growth include the rising incidence of diabetes, ...

With the new school year well underway, provincial governments are implementing new health and safety policies, including classroom cellphone bans and requirements for automated external ...

CHAMBERS COUNTY, Texas – The sentencing phase will resume on Thursday after jurors found Sarah Hartsfield guilty of murdering her husband in 2023, after hearing nearly two hours of closing arguments ...

The difference between type 1 and type 2 diabetes is that people with type 2 have a wider variety of treatment options.

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. On one wall of endocrinologist Kevan Herold’s ...